| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6068590 | The Journal of Allergy and Clinical Immunology: In Practice | 2014 | 14 Pages |
Abstract
Asthma exacerbation was lower for BFC versus FSC initiators due to lower rates of oral corticosteroid use and asthma-related emergency department visits, which indicate better treatment effectiveness of those patients initiated with BFC compared with FSC.
Keywords
PDCBFCFSCOCsICSlong-acting β2-adrenergic agonistGERDSABADCILTRAAsthmaLeukotriene receptor antagonistComparative effectivenessemergency departmentgastroesophageal reflux diseaseLABARetrospective cohort studyproportion of days coveredodds ratioRate Ratiooral corticosteroidInhaled corticosteroidsInhaled corticosteroid
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ozgur PhD, Setareh A. PhD, David M. MS, Hanaa MD, MS, MPH, Ned MBA, Catrin PhD, Siting PhD, Frank MD,